Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03127514
Previous Study | Return to List | Next Study

AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) (CENTAUR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03127514
Recruitment Status : Completed
First Posted : April 25, 2017
Last Update Posted : November 3, 2020
Sponsor:
Collaborators:
ALS Finding a Cure Foundation
ALS Association
Northeast ALS Consortium
Massachusetts General Hospital Neurology Clinical Research Institute
Leandro P. Rizzuto Foundation
Information provided by (Responsible Party):
Amylyx Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 25, 2019
Actual Study Completion Date : November 24, 2019
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):